[Federal Register: December 10, 2007 (Volume 72, Number 236)]
[Rules and Regulations]               
[Page 69618]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10de07-23]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR Part 1308

[Docket No. DEA-309F]

 
Designation of Oripavine as a Basic Class of Controlled 
Substance; Correction

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Final rule; correcting amendments.

-----------------------------------------------------------------------

SUMMARY: On September 24, 2007, the Drug Enforcement Administration 
(DEA) published in the Federal Register a final rule (72 FR 54208) 
designating oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-
4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol) as a basic class in 
schedule II of the Controlled Substances Act (CSA). The drug code for 
oripavine was inadvertently designated as 9335, a drug code which is 
already used to identify a schedule I controlled substance. This 
correction corrects that error and assigns a different drug code to 
oripavine.

DATES: Effective December 10, 2007.

FOR FURTHER INFORMATION CONTACT: Christine A. Sannerud, PhD, Chief, 
Drug and Chemical Evaluation Section, Drug Enforcement Administration, 
Washington, DC 20537, by e-mail, ode@dea.usdoj.gov or by fax, (202) 
353-1263.

SUPPLEMENTARY INFORMATION: On September 24, 2007, the Drug Enforcement 
Administration (DEA) published a Final Rule in the Federal Register (72 
FR 54208) designating oripavine (3- O-demethylthebaine or 6,7,8,14-
tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol) as a 
basic class in schedule II of the Controlled Substances Act (CSA). In 
the final rule, the drug code for oripavine was inadvertently listed as 
9335. This is the drug code for the schedule I controlled substance, 
drotebanol. Upon publication of this rule, the drug code for oripavine 
will be amended to 9330.

0
Accordingly, 21 CFR part 1308 is corrected by making the following 
correcting amendments:

PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES

0
1. The authority citation for part 1308 continues to read as follows:

    Authority: 21 U.S.C. 811, 812, 871(b), unless otherwise noted.


0
2. Section 1308.12(b)(1) is amended by revising the entry (xii) to read 
as follows:


Sec.  1308.12  Schedule II.

* * * * *
    (b) * * *
    (1) * * *
* * * * *

(xii) Oripavine.................................................    9330


* * * * *

    Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control.
[FR Doc. E7-23759 Filed 12-7-07; 8:45 am]

BILLING CODE 4410-09-P